Within3 is Committed to Providing the Most Relevant Information in the Industry

Reach Global Payers Where They Are

December 28, 2016 | Case Study

When designing new drugs, pharmaceutical companies need to seek the input of key stakeholders – physicians, patients, payers. The goal is to achieve greater information exchange and data-mining capabilities about several key factors, including strategies payers employ to determine therapies and/or rein in costs.

Read More

Improving Communications Within Clinical Trials

December 13, 2016 | Case Study

Clinical trials are known to involve hundreds of physicians and thousands of patients from all around the world at any given time. Many sites can also run multiple trials simultaneously, making it difficult to manage ongoing operations, while providing continuous support and seamless communications between all participants.

Read More

A Look at Part Two of Our Innovators in Life Sciences Webinar Series

November 30, 2016 | Blog

On Friday, November 11th, 2016, we presented the second of our 3-part Innovators in Life Sciences series.  In this segment, Lance Hill, CEO of Within3, and Remy Guidry, Group Account Supervisor of DDB Health, demonstrated how pharmaceutical companies can increase, and even improve, interactions with their stakeholders while successfully reducing related costs. By leveraging online discussion platforms, commercial, medical affairs, and digital innovation teams have the ability to remove travel, time zone, and language barriers often associated with live and video-based meetings.

Read More

Optimizing a Speakers Bureau Program in Healthcare and Life Sciences

October 31, 2016 | Article

In pharma, speakers bureaus are used for accelerating awareness and clinical expertise of important new treatments. Doctors and other HCPs use real-world clinical experience to educate and inform peers of different therapies for a particular disease. But, launching a speakers bureau is more than creating a PowerPoint presentation, contracting a speaker and inviting healthcare professionals to listen to your program. 

Read More

Regional Physician Program

October 28, 2016 | Case Study

Gathering key stakeholders from different regions is not always feasible. It’s challenging to assemble 80-100 HCPs from around the country to discuss topics that impact the healthcare industry, such as updated treatment guidelines. But, in order to understand the implications of treatment decisions due to new guidelines, a pharma company needed to quickly engage multiple physicians from different parts of the country in meaningful dialogue.

Read More